Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print PCI preference -- will that be an arm or a leg?

PCI preference -- will that be an arm or a leg?

July 21, 2008

DURHAM, N.C. - When it comes to stenting - using metal tubes to prop open blocked arteries - physicians are continuing to choose to gain entry to the circulatory system through an opening in the leg instead of the arm, even though the latter option appears to be safer, with fewer side effects, say researchers at Duke Clinical Research Institute.

"Bleeding complications are reduced by 70 percent when interventional cardiologists go in through a radial artery in the wrist," says Dr. Sunil Rao, a cardiologist at Duke and the lead author of the study. "But our research shows that only a tiny fraction of stenting procedures are done this way. The study suggests that maybe it's time to change the way we practice."




Researchers reviewed data from 593,094 cases of percutaneous coronary intervention (PCI) in 606 hospitals across the U.S. included in the National Cardiovascular Data Registry from 2004 to 2007. They tracked the incidence of radial PCI (r-PCI) versus leg or femoral PCI (f-PCI) during that period and calculated which patients were more likely to get which option.

They found that the arm approach had gained favor over the four-year period, but still comprised only 1.3 percent of the total number of procedures. They also found that 40 percent of radial PCI was performed in only seven centers. Academic medical centers were more likely to be sites of higher r-PCI use than centers not affiliated with a college or university.

The data further revealed that r-PCI was more likely to be chosen as an approach for younger patients, those with significantly higher body mass index and patients with a higher prevalence of peripheral vascular disease

The study appears in the August issue of Journal of the American College of Cardiology: Cardiovascular Intervention. The study was funded by the National Cardiovascular Data Registry and the American College of Cardiology.

"The findings are somewhat surprising, given that numerous studies have shown that r-PCI is similarly successful to f-PCI, and that r-PCI can significantly lower risk of bleeding, especially among women, patients younger than 75 and people undergoing PCI for acute coronary syndrome," says Rao. He says previous studies have also shown that r-PCI may cost less because it can mean shorter time in the hospital for some patients.

A decade's worth of skilled training and technical advances in stent design has contributed to an increased safety profile for most stenting procedures. But Rao says bleeding can be a complication in about 10 percent of some procedures. While most bleeding is minor, such bleeding can be life-threatening in a small number of cases. PCI also carries a slight risk of death from blood clots or ruptured arterial walls.

Rao uses r-PCI himself almost exclusively, reserving f-PCI for three types of cases: where the catheter is too big to fit inside the radial artery; in cases where the patient has had coronary bypass surgery, which can complicate access from the left wrist; or in cases where there is no alternate blood flow to the hand.

Rao notes that r-PCI is the preferred option in Europe. He says slower acceptance of the technique in the United States may be due to normal resistance to change, resistance to having to master a new learning curve and a lack of industry effort to market new devices specially designed for r-PCI.

Duke University Medical Center



Related Percutaneous Coronary Intervention Current Events and Percutaneous Coronary Intervention News Articles Percutaneous Coronary Intervention Current Events and Percutaneous Coronary Intervention News RSS Percutaneous Coronary Intervention Current Events and Percutaneous Coronary Intervention News RSS
New appropriate use criteria guide treatment of patients with heart blockage
If you're committed to fitness, the decision to climb a couple of flights of stairs rather than take the elevator is clear. But if you develop chest pain on the way up, deciding how to treat the symptoms of clogged arteries in your heart is much more complicated.

HORIZONS AMI will help set guidelines for drug and stent therapy
The HORIZONS AMI clinical trial measuring the safety and efficacy of the use of the medication bivalirudin compared to standard drug therapy - heparin and glycoprotein IIb/IIIa inhibitors -- in heart attack patients who receive angioplasty, found that after 1 year, use of bivalirudin resulted in significantly lower rates of all-cause death, death from cardiac causes, and major bleeding.

Stress tests to confirm need for cardiac stent not occurring in most patients, new study finds
UCSF researchers investigating the appropriate use of procedures to open narrowed coronary arteries -- such as angioplasty and stenting -- found that less than half of Medicare patients had documented noninvasive stress testing prior to elective percutaneous coronary intervention, or PCI, the clinical name for such procedures.

Triple antiplatelet therapy appears superior to dual antiplatelet therapy
Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents achieves greater platelet inhibition than conventional dual antiplatelet therapy.

New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008
Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

DES: New elements in the debate
Results announced at the 2006 ESC meeting in Barcelona questioned the long-term safety of drug eluting stents (DES) and sparked intense discussion.

Findings released from 1 of the largest percutaneous coronary intervention trials ever
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).

Comparison of anticoagulants for angioplasty show similar outcomes
In a comparison of anticoagulants and stents for use with angioplasty following a heart attack, the anticoagulants abciximab and tirofiban had similar outcomes for some cardiac measures within 90 minutes after the procedure, while patients who received stents that released the drug sirolimus had a lower risk of major adverse cardiac events within 8 months than patients who received uncoated stents.

Novel compound may lessen heart attack damage
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute. Results of the study, available online and to be published in the February 19 issue of the journal Circulation, reflect the first time the drug has been tested in humans.

Top 10 research advances include studies on genetics and stem cell research, stents
Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents to clear coronary artery blockages are among the top research advances in heart disease and stroke for 2007, said Daniel W. Jones, M.D., president of the American Heart Association.
More Percutaneous Coronary Intervention Current Events and Percutaneous Coronary Intervention News Articles


Complications of Percutaneous Coronary Interventions

This book complements available texts that detail percutaneous coronary interventions and is dedicated solely to the associated complications. By covering the range of complications that arise, from medication related to difficulties with closure devices, this text helps physicians improve care by anticipating or recognizing problems earlier. Chapters focus on specific steps of interventions and...



Common Clinical Dilemmas in Percutaneous Coronary Interventions

Coronary stenting is the most commonly used method of myocardial revascularization, with approximately 2 million stents implanted in 2004 throughout the world. The development of drug eluting stents has resulted in very low rates of repeat intervention and will further increase the scope for percutaneous coronary intervention. The evidence from large randomized trials is generally accepted to be...

CABG relieves angina better than PCI.(Cardiovascular Medicine)(coronary artery bypass grafting)(percutaneous coronary intervention ): An article from: Family Practice News
by Mary Ann Moon

This digital document is an article from Family Practice News, published by Thomson Gale on November 1, 2007. The length of the article is 440 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: CABG...

CABG rates plummet as PCI rates rise in Washington state. (Reflect Procedures' Future).(percutaneous coronary interventions)(Coronary artery bypass grafts)(Brief ... An article from: Family Practice News
by Mitchel L. Zoler

This digital document is an article from Family Practice News, published by International Medical News Group on July 1, 2003. The length of the article is 6766 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Extra-cardiac Risk Factors for Percutaneous Coronary Interventions (Berichte Aus Der Medizin)
by Holger Reinecke

Large database solves obesity paradox in PCI outcomes.(Cardiovascular Medicine)(percutaneous coronary intervention): An article from: Internal Medicine News
by Mitchel L. Zoler

This digital document is an article from Internal Medicine News, published by International Medical News Group on June 1, 2004. The length of the article is 478 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

PCI beats thrombolysis in elderly MI patients.(Cardiovascular Medicine)(percutaneous coronary intervention) : An article from: Family Practice News
by Bruce Jancin

This digital document is an article from Family Practice News, published by Thomson Gale on March 15, 2006. The length of the article is 648 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: PCI...

PCI rates go up as CABG rates go down in the South. (CABG Mostly for Multivessel Disease).(percutaneous coronary interventions)(Coronary artery bypass graft ): An article from: Family Practice News
by Doug Brunk

This digital document is an article from Family Practice News, published by International Medical News Group on July 1, 2003. The length of the article is 493 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

PCI displacing CABG in Washington state; 128% rise in PCI rate for 1987-2001. (percutaneous coronary interventions, coronary artery bypass graft).(Cardiovascular ... An article from: Internal Medicine News
by Mitchel L. Zoler

This digital document is an article from Internal Medicine News, published by International Medical News Group on October 1, 2003. The length of the article is 1235 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web...

Simultaneous percutaneous atrial septal defect closure and percutaneous coronary intervention/Perkutan koroner girisim ve atriyal septal defektin perkutan ... of Cardiology (Anadolu Kardiyoloji Dergisi)
by Massimo Chessa, Massimo Medda, Ayman Moharram, Gianfranco Butera, Claudio Bussadori, Carlo Vigna, Mario Carminati

This digital document is an article from The Anatolian Journal of Cardiology (Anadolu Kardiyoloji Dergisi), published by Thomson Gale on March 1, 2007. The length of the article is 1947 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with...

© 2009 BrightSurf.com